Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases

Immunopharmacology

Volumn 33, Issue 1-3, 1996, Pages 32-35

  Braun, Andreas ^a   Kammerer, Stefan ^a   Maier, Esther ^a   Böhme, Eike ^a   Röscher, Adelbert A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

bradykinin; genetic risk; human B2 receptor gene; polymorphism

Indexed keywords

BRADYKININ B2 RECEPTOR;

ALLELE; ALLERGIC ASTHMA; CONFERENCE PAPER; EXON; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HYPERTENSION; HYPOTHESIS; ISCHEMIC HEART DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0030175320     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00079-3     Document Type: Conference Paper

References (5)

1. 2 receptor gene. Biochem Biophys Res Comm 1995; 211: 234-240.
2. Hess JF, Borkowski JA, Young GS, Strader CD, Ransom RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Comm 1992; 184: 260-268.
3. 2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Comm 1995; 211: 226-233.
4. Müller B. Clerget-Darpoux F. A test based on the exact probability distribution of the chi-square statistic-incorporation into the MASC method. Ann Hum Genet 1991; 55: 69-75.
5. Ross J. mRNA stability in mammalian cells (review). Microbiol Rev 1995; 59: 423-450.